Lucy Boyce Kennedy,April K S Salama
Lucy Boyce Kennedy
The use of checkpoint inhibitor-based immunotherapy has transformed the treatment landscape for melanoma as well as many other cancer types. With the ability to potentiate tumor-specific immune responses, these agents can result in durable ...
Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1 [0.03%]
高表达EVI1的高危急性髓系白血病ARA化疗联合全反式维甲酸治疗疗效分析
Etienne Paubelle,Adriana Plesa,Sandrine Hayette et al.
Etienne Paubelle et al.
Introduction: EVI1 (MECOM)-positive acute myeloid leukemia (AML) cells have shown in vitro sensitivity to all-trans-retinoic acid (ATRA) by inducing differentiation, cell death, and decreased leukemic engraftment. ...
Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study [0.03%]
用于无残存病灶的III期卵巢癌患者一线维持治疗的尼拉帕利：AR1ZE真实世界研究
Introduction: Niraparib was approved for first-line (1L) maintenance (1LM) treatment of patients with advanced epithelial ovarian cancer (EOC) following the PRIMA/ENGOT-OV26/GOG-3012 (PRIMA) trial. PRIMA was restricted to...
Real-World Observational Study of Incidence and Outcomes in an HR+/HER2- Early Breast Cancer Population with High-Risk of Recurrence in Finland [0.03%]
在芬兰高危复发的HR+/HER2-早期乳腺癌人群中发病率和预后的现实世界观察研究
Introduction: Real-world data on patients with early breast cancer (EBC) with high-risk features remains limited. This population-based study determined the incidence, outcomes and characteristics of patients with hormone...